Selective inhibition of cyclooxygenase 2 spares renal function and prostaglandin synthesis in cirrhotic rats with ascites
| Autor: | Rosario Altuna, J.L. Poo, Marta Bosch–Marcé, Jaime L. Masferrer, Vicente Arroyo, Wladimiro Jiménez, Esther Titos, Joan Rodés, Francisca Rivera, Joan Clària |
|---|---|
| Rok vydání: | 1999 |
| Předmět: |
Male
medicine.medical_specialty Cirrhosis Renal function Urine Pharmacology Kidney Kidney Function Tests Liver Cirrhosis Experimental Body Water Internal medicine Ascites medicine Animals Cyclooxygenase Inhibitors RNA Messenger Rats Wistar Tolmetin Carbon Tetrachloride Blood urea nitrogen Sulfonamides Cyclooxygenase 2 Inhibitors Hepatology biology business.industry Hemodynamics Gastroenterology Membrane Proteins Kidney metabolism medicine.disease Rats Isoenzymes Endocrinology Cyclooxygenase 2 Prostaglandin-Endoperoxide Synthases Renal blood flow Renal physiology Cyclooxygenase 1 Prostaglandins biology.protein Pyrazoles Cyclooxygenase medicine.symptom business Ketorolac Glomerular Filtration Rate |
| Zdroj: | Gastroenterology. 116:1167-1175 |
| ISSN: | 0016-5085 |
| DOI: | 10.1016/s0016-5085(99)70020-x |
| Popis: | Background & Aims: The critical role of cyclooxygenase (COX) products in maintenance of renal function in cirrhosis with ascites discourages the use of nonsteroidal anti-inflammatory drugs in this disease. The recent development of selective COX-2 inhibitors opens new avenues for the use of these compounds in decompensated cirrhosis. The current study evaluates the effects of a selective COX-2 inhibitor (SC-236) on renal function in cirrhotic rats with ascites. Methods: In protocol 1, urine volume, urinary excretion of sodium and prostaglandins, glomerular filtration rate, and renal plasma flow were measured before and after administration of SC-236 (n = 12) or ketorolac (n = 10) to rats with cirrhosis. Protocol 2 was aimed at assessing the effects of COX inhibitors on renal water metabolism in 28 cirrhotic rats. Results: Administration of SC-236 to cirrhotic animals did not produce significant renal effects, whereas administration of the nonselective COX-1/COX-2 inhibitor, ketorolac, resulted in a marked reduction in urine volume, urinary excretion of prostaglandins, and glomerular filtration rate and in a significant impairment in renal water metabolism. Conclusions: These findings indicate that SC-236 does not significantly impair renal function in rats with cirrhosis. GASTROENTEROLOGY 1999;116:1167-1175 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|